Is hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer?

Journal of Urology

Volumn 172, Issue 5 I, 2004, Pages 1856-1859

  Lam, John S ^a   Sclar, Joshua D ^a   Desai, Manisha ^a   Mansukhani, Mahesh M ^a   Benson, Mitchell C ^a   Goluboff, Erik T ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital ^*  (United States)

Author keywords

Hispanic Americans; Outcome assessment; Prostatectomy; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; FOLLOW UP; HISPANIC; HISTOPATHOLOGY; HUMAN; MALE; NEGRO; PHYSICAL EXAMINATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RISK FACTOR; TREATMENT FAILURE;

EID: 5444257480     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000141783.67470.55     Document Type: Article

References (19)

1. Grieco, E. M. and Cassidy, R. C.: Overview of race and Hispanic origin: 2000. Census 2000 Brief. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, 2001. Available at http://www.census.gov/ prod/2001pubs/c2kbr01-1.pdf. Accessed August 4, 2004
2. O'Brien, K., Cokkinides, V., Jemal, A., Cardinez, C. J., Murray, T., Samuels, A. et al: Cancer statistics for Hispanics, 2003. CA Cancer J Clin, 53: 208, 2003
3. Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Stanford, J. L. et al: Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst, 93: 388, 2001
4. Zietman, A., Moughan, J., Owen, J. and Hanks, G.: The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas. Int J Radiat Oncol Biol Phys, 50: 75, 2001
5. Danley, K. L., Richardson, J. L., Bernstein, L., Langholz, B. and Ross, R. K.: Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control, 6: 492, 1995
6. Delfino, R. J., Ferrini, R. L., Taylor, T. H., Howe, S. and Anton-Culver, H.: Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California. Am J Prev Med, 14: 96, 1998
7. Lam, J. S., Desai, M., Mansukhani, M. M., Benson, M. C. and Goluboff, E. T.: Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy? J Urol, 170: 2288, 2003
8. Fowler, J. E., Jr. and Terrell, F.: Survival in blacks and whites after treatment for localized prostate cancer. J Urol, 156: 133, 1996
9. Moul, J. W., Douglas, T. H., McCarthy, W. F. and McLeod, D. G.: Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol, 155: 1667, 1996
10. Powell, I. J., Heilburn, L. K., Sakr, W., Grignon, D., Montie, J., Novallo, M. et al: The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins. Urology, 49: 726, 1997
11. Sohayda, C. J., Kupelian, P. A., Altsman, K. A. and Klein, E. A.: Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol, 162: 1331, 1999
12. Eastham, J. A. and Kattan, M. W.: Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol, 163: 143, 2000
13. Moul, J. W., Connelly, R. R., Lubeck, D. P., Bauer, J. J., Sun, L., Flanders, S. C. et al: Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol, 166: 1322, 2001
14. Freedland, S. J., Amling, C. L., Dorey, F., Kane, C. J., Presti, J. C., Jr., Terris, M. K. et al: Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology, 66: 670, 2002
15. Rosser, C. J., Kuban, D. A., Levy, L. B., Pettaway, C. A., Chichakli, R., Kamat, A. M. et al: Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy. J Urol, 170: 1856, 2003
16. Makridakis, N. M., Ross, R. K., Pike, M. C., Crocitto, L. E., Kolonel, L. N., Pearce, C. L. et al: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet, 354: 975, 1999
17. Stamey, T., Yang, N., Hay, A., McNeal, J. E., Freiha, F. S. and Redwine, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 317: 909, 1987
18. Stewart, S. L., Swallen, K. C., Glaser, S. L., Horn-Ross, P. L. and West, D. W.: Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol, 149: 1063, 1999
19. Partin, A. W., Pearson, J. D., Landis, P. K., Carter, H. B., Pound, C. R., Clemens, J. Q. et al: Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology, 43: 649, 1994